Mitchell Harris1, Jacob J Kinnun2, Rasagna Kosaraju1, Xiaoling Leng2, Stephen R Wassall2, Saame Raza Shaikh3. 1. Department of Biochemistry and Molecular Biology, East Carolina Diabetes and Obesity Institute, Brody School of Medicine, East Carolina University, Greenville, NC; and. 2. Department of Physics, Indiana University-Purdue University Indianapolis, Indianapolis, IN. 3. Department of Biochemistry and Molecular Biology, East Carolina Diabetes and Obesity Institute, Brody School of Medicine, East Carolina University, Greenville, NC; and shaikhsa@ecu.edu.
Abstract
BACKGROUND: Plasma membrane organization is a mechanistic target of n-3 (ω-3) polyunsaturated fatty acids. Previous studies show that eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3) differentially disrupt plasma membrane molecular order to enhance the frequency and function of B lymphocytes. However, it is not known whether EPA and DHA affect the plasma membrane organization of B lymphomas differently to influence their function. OBJECTIVE: We tested whether EPA and DHA had different effects on membrane order in B lymphomas and liposomes and studied their effects on B-lymphoma growth. METHODS: B lymphomas were treated with 25 μmol EPA, DHA, or serum albumin control/L for 24 h. Membrane order was measured with fluorescence polarization, and cellular fatty acids (FAs) were analyzed with GC. Growth was quantified with a viability assay. (2)H nuclear magnetic resonance (NMR) studies were conducted on deuterated phospholipid bilayers. RESULTS: Treating Raji, Ramos, and RPMI lymphomas for 24 h with 25 μmol EPA or DHA/L lowered plasma membrane order by 10-40% relative to the control. There were no differences between EPA and DHA on membrane order for the 3 cell lines. FA analyses revealed complex changes in response to EPA or DHA treatment and a large fraction of EPA was converted to docosapentaenoic acid (DPA; 22:5n-3). NMR studies, which were used to understand why EPA and DHA had similiar membrane effects, showed that phospholipids containing DPA, similar to DHA, were more ordered than those containing EPA. Finally, treating B lymphomas with 25 μmol EPA or DHA/L did not increase the frequency of B lymphomas compared with controls. CONCLUSIONS: The results establish that 25 μmol EPA and DHA/L equally disrupt membrane order and do not promote B lymphoma growth. The data open a new area of investigation, which is how EPA's conversion to DPA substantially moderates its influence on membrane properties.
BACKGROUND: Plasma membrane organization is a mechanistic target of n-3 (ω-3) polyunsaturated fatty acids. Previous studies show that eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3) differentially disrupt plasma membrane molecular order to enhance the frequency and function of B lymphocytes. However, it is not known whether EPA and DHA affect the plasma membrane organization of B lymphomas differently to influence their function. OBJECTIVE: We tested whether EPA and DHA had different effects on membrane order in B lymphomas and liposomes and studied their effects on B-lymphoma growth. METHODS:B lymphomas were treated with 25 μmol EPA, DHA, or serum albumin control/L for 24 h. Membrane order was measured with fluorescence polarization, and cellular fatty acids (FAs) were analyzed with GC. Growth was quantified with a viability assay. (2)H nuclear magnetic resonance (NMR) studies were conducted on deuterated phospholipid bilayers. RESULTS: Treating Raji, Ramos, and RPMI lymphomas for 24 h with 25 μmol EPA or DHA/L lowered plasma membrane order by 10-40% relative to the control. There were no differences between EPA and DHA on membrane order for the 3 cell lines. FA analyses revealed complex changes in response to EPA or DHA treatment and a large fraction of EPA was converted to docosapentaenoic acid (DPA; 22:5n-3). NMR studies, which were used to understand why EPA and DHA had similiar membrane effects, showed that phospholipids containing DPA, similar to DHA, were more ordered than those containing EPA. Finally, treating B lymphomas with 25 μmol EPA or DHA/L did not increase the frequency of B lymphomas compared with controls. CONCLUSIONS: The results establish that 25 μmol EPA and DHA/L equally disrupt membrane order and do not promote B lymphoma growth. The data open a new area of investigation, which is how EPA's conversion to DPA substantially moderates its influence on membrane properties.
Authors: Brian M Stott; Mai P Vu; Chisako O McLemore; M Shaun Lund; Elizabeth Gibbons; Taylor J Brueseke; Heather A Wilson-Ashworth; John D Bell Journal: J Lipid Res Date: 2008-02-25 Impact factor: 5.922
Authors: Saame Raza Shaikh; Michael R Brzustowicz; Noah Gustafson; William Stillwell; Stephen R Wassall Journal: Biochemistry Date: 2002-08-27 Impact factor: 3.162
Authors: Eric A Gurzell; Heather Teague; Mitchel Harris; Jonathan Clinthorne; Saame Raza Shaikh; Jenifer I Fenton Journal: J Leukoc Biol Date: 2012-11-24 Impact factor: 4.962
Authors: Laura Miguel; Dylan M Owen; Chrissie Lim; Christian Liebig; Jamie Evans; Anthony I Magee; Elizabeth C Jury Journal: J Immunol Date: 2011-02-09 Impact factor: 5.422
Authors: Xiaoling Leng; Jacob J Kinnun; Andres T Cavazos; Samuel W Canner; Saame Raza Shaikh; Scott E Feller; Stephen R Wassall Journal: Biochim Biophys Acta Biomembr Date: 2018-01-03 Impact factor: 3.747
Authors: Michele R Plewes; Patrick D Burns; Richard M Hyslop; B George Barisas Journal: Biochim Biophys Acta Biomembr Date: 2017-09-11 Impact factor: 3.747
Authors: Joanne J Liu; Adrienne Hezghia; Saame Raza Shaikh; Joshua F Cenido; Ruth E Stark; J John Mann; M Elizabeth Sublette Journal: Neuropsychopharmacology Date: 2018-06-28 Impact factor: 7.853
Authors: E Madison Sullivan; Edward Ross Pennington; William D Green; Melinda A Beck; David A Brown; Saame Raza Shaikh Journal: Adv Nutr Date: 2018-05-01 Impact factor: 8.701
Authors: Milad Moloudizargari; Esmaeil Mortaz; Mohammad Hossein Asghari; Ian M Adcock; Frank A Redegeld; Johan Garssen Journal: Oncotarget Date: 2018-02-05
Authors: Joshua F Ceñido; Boris Itin; Ruth E Stark; Yung-Yu Huang; Maria A Oquendo; J John Mann; M Elizabeth Sublette Journal: Biochem Biophys Rep Date: 2017-03-20